KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Inventory (2017 - 2025)

Cigna (CI) has disclosed Inventory for 9 consecutive years, with $7.3 billion as the latest value for Q4 2025.

  • Quarterly Inventory rose 9.65% to $7.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 billion through Dec 2025, up 9.65% year-over-year, with the annual reading at $7.3 billion for FY2025, 9.65% up from the prior year.
  • Inventory hit $7.3 billion in Q4 2025 for Cigna, up from $5.6 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $7.3 billion in Q4 2025 to a low of $2.9 billion in Q1 2021.
  • Historically, Inventory has averaged $4.7 billion across 5 years, with a median of $4.6 billion in 2023.
  • Biggest five-year swings in Inventory: soared 33.01% in 2022 and later rose 9.65% in 2025.
  • Year by year, Inventory stood at $3.7 billion in 2021, then rose by 28.34% to $4.8 billion in 2022, then rose by 18.17% to $5.6 billion in 2023, then increased by 18.55% to $6.7 billion in 2024, then grew by 9.65% to $7.3 billion in 2025.
  • Business Quant data shows Inventory for CI at $7.3 billion in Q4 2025, $5.6 billion in Q3 2025, and $6.0 billion in Q2 2025.